Some Investing Thoughts On Adaptimmune Therapeutics Plc ADR (NASDAQ: ADAP)
Adaptimmune Therapeutics Plc ADR (ADAP) concluded trading on Thursday at a closing price of $0.33, with 3.61 million shares of worth about $1.19 million changed hands on the day. Half year performance of the stock remained negative as price took a plunge of -42.18% during that period and on July 24, 2025 the price saw […]
Adaptimmune Therapeutics Plc ADR (NASDAQ: ADAP): Analyst View Points To Future Growth
Adaptimmune Therapeutics Plc ADR (ADAP) concluded trading on Thursday at a closing price of $0.25, with 0.46 million shares of worth about $0.11 million changed hands on the day. Half year performance of the stock remained negative as price took a plunge of -54.87% during that period and on July 03, 2025 the price saw […]
Adaptimmune Therapeutics Plc ADR (NASDAQ: ADAP) – Suitable For Long Term Buy?
Insiders at the company have transacted a total of 0 times over the past 12 months, according to data filed with the U.S. Securities and Exchange Commission (SEC). 0 of these insider trades were purchases, accounting for 0 shares. Insider sales of the common stock occurred on 0 occasions, with total insider shares sold totaling […]